SITPIN D 10/100
SITPIN D 10/100 is a combination therapy used for effective control of type 2 diabetes mellitus. Each film-coated tablet contains Sitagliptin 100 mg + Dapagliflozin 10 mg. Sitagliptin improves insulin secretion and reduces glucagon levels, while Dapagliflozin helps eliminate excess glucose through urine. This dual mechanism supports better glycemic control, helps reduce HbA1c levels, and contributes to improved overall metabolic health in diabetic patients.
Related products
SITPIN 100
SITPIN 100 contains Sitagliptin 100 mg, a DPP-4 inhibitor used to manage blood sugar levels...
LINANTA M 1000
LINANTA M 1000 contains Linagliptin 2.5 mg + Metformin Hydrochloride 1000 mg, a powerful combination...
LINANTA 5
LINANTA 5 contains Linagliptin 5 mg, an effective DPP-4 inhibitor used in the management of...
GLIPDIP M FORTE
GLIPDIP M FORTE is a combination therapy designed for better control of type 2 diabetes...
GLIPDIP
GLIPDIP is used for the management of type 2 diabetes mellitus. Each tablet contains Teneligliptin...
GLIBEN PM TAB
GLIBEN PM Tablet is a triple combination therapy used for effective management of type 2...
DUET ACT 2 FORTE
DUET ACT 2 FORTE Tablet is a combination medicine used for effective management of type...
DUET ACT 1
DUET ACT 1 contains Glimepiride 1 mg and Metformin 500 mg (SR). It works by...
